Stay updated with breaking news from Nasdaq Atra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has earned an average recommendation of “Hold” from the eight analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) CFO Utpal Koppikar sold 5,582 shares of Atara Biotherapeutics stock in a transaction on Tuesday, May 17th. The stock was sold at an average price of $5.32, for a total transaction of $29,696.24. Following the completion of the transaction, the chief financial officer now directly owns 207,592 shares […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) SVP Amar Murugan sold 3,223 shares of Atara Biotherapeutics stock in a transaction on Tuesday, May 17th. The stock was sold at an average price of $5.32, for a total value of $17,146.36. Following the sale, the senior vice president now owns 133,735 shares in the company, valued […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) EVP Jakob Dupont sold 3,873 shares of the business’s stock in a transaction dated Tuesday, May 17th. The stock was sold at an average price of $5.32, for a total transaction of $20,604.36. Following the sale, the executive vice president now owns 163,006 shares in the company, valued […]
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) have received a consensus recommendation of “Buy” from the seven research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have assigned a buy recommendation to the […]